Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1981 6
1982 5
1983 6
1984 3
1985 8
1986 12
1987 14
1988 15
1989 13
1990 15
1991 16
1992 14
1993 16
1994 17
1995 19
1996 15
1997 16
1998 17
1999 13
2000 14
2001 12
2002 10
2003 15
2004 13
2005 18
2006 12
2007 14
2008 14
2009 18
2010 15
2011 17
2012 13
2013 22
2014 7
2015 16
2016 10
2017 12
2018 17
2019 9
2020 13
2021 9
2022 4
2023 1
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

537 results

Results by year

Filters applied: . Clear all
Page 1
Treg cell-based therapies: challenges and perspectives.
Raffin C, Vo LT, Bluestone JA. Raffin C, et al. Among authors: bluestone ja. Nat Rev Immunol. 2020 Mar;20(3):158-172. doi: 10.1038/s41577-019-0232-6. Epub 2019 Dec 6. Nat Rev Immunol. 2020. PMID: 31811270 Free PMC article. Review.
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
Herold KC, Bundy BN, Long SA, Bluestone JA, DiMeglio LA, Dufort MJ, Gitelman SE, Gottlieb PA, Krischer JP, Linsley PS, Marks JB, Moore W, Moran A, Rodriguez H, Russell WE, Schatz D, Skyler JS, Tsalikian E, Wherrett DK, Ziegler AG, Greenbaum CJ; Type 1 Diabetes TrialNet Study Group. Herold KC, et al. Among authors: bluestone ja. N Engl J Med. 2019 Aug 15;381(7):603-613. doi: 10.1056/NEJMoa1902226. Epub 2019 Jun 9. N Engl J Med. 2019. PMID: 31180194 Free PMC article. Clinical Trial.
Next-generation regulatory T cell therapy.
Ferreira LMR, Muller YD, Bluestone JA, Tang Q. Ferreira LMR, et al. Among authors: bluestone ja. Nat Rev Drug Discov. 2019 Oct;18(10):749-769. doi: 10.1038/s41573-019-0041-4. Epub 2019 Sep 20. Nat Rev Drug Discov. 2019. PMID: 31541224 Free PMC article. Review.
Multiple early factors anticipate post-acute COVID-19 sequelae.
Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, Li S, Hong S, Zhang R, Xie J, Kornilov SA, Scherler K, Pavlovitch-Bedzyk AJ, Dong S, Lausted C, Lee I, Fallen S, Dai CL, Baloni P, Smith B, Duvvuri VR, Anderson KG, Li J, Yang F, Duncombe CJ, McCulloch DJ, Rostomily C, Troisch P, Zhou J, Mackay S, DeGottardi Q, May DH, Taniguchi R, Gittelman RM, Klinger M, Snyder TM, Roper R, Wojciechowska G, Murray K, Edmark R, Evans S, Jones L, Zhou Y, Rowen L, Liu R, Chour W, Algren HA, Berrington WR, Wallick JA, Cochran RA, Micikas ME; ISB-Swedish COVID-19 Biobanking Unit; Wrin T, Petropoulos CJ, Cole HR, Fischer TD, Wei W, Hoon DSB, Price ND, Subramanian N, Hill JA, Hadlock J, Magis AT, Ribas A, Lanier LL, Boyd SD, Bluestone JA, Chu H, Hood L, Gottardo R, Greenberg PD, Davis MM, Goldman JD, Heath JR. Su Y, et al. Among authors: bluestone ja. Cell. 2022 Mar 3;185(5):881-895.e20. doi: 10.1016/j.cell.2022.01.014. Epub 2022 Jan 25. Cell. 2022. PMID: 35216672 Free PMC article.
Tolerance in the Age of Immunotherapy.
Bluestone JA, Anderson M. Bluestone JA, et al. N Engl J Med. 2020 Sep 17;383(12):1156-1166. doi: 10.1056/NEJMra1911109. N Engl J Med. 2020. PMID: 32937048 Free PMC article. Review. No abstract available.
Revisiting IL-2: Biology and therapeutic prospects.
Abbas AK, Trotta E, R Simeonov D, Marson A, Bluestone JA. Abbas AK, et al. Among authors: bluestone ja. Sci Immunol. 2018 Jul 6;3(25):eaat1482. doi: 10.1126/sciimmunol.aat1482. Sci Immunol. 2018. PMID: 29980618 Review.
New Frontiers in the Treatment of Type 1 Diabetes.
Warshauer JT, Bluestone JA, Anderson MS. Warshauer JT, et al. Among authors: bluestone ja. Cell Metab. 2020 Jan 7;31(1):46-61. doi: 10.1016/j.cmet.2019.11.017. Epub 2019 Dec 12. Cell Metab. 2020. PMID: 31839487 Free PMC article. Review.
CD28 Costimulation: From Mechanism to Therapy.
Esensten JH, Helou YA, Chopra G, Weiss A, Bluestone JA. Esensten JH, et al. Among authors: bluestone ja. Immunity. 2016 May 17;44(5):973-88. doi: 10.1016/j.immuni.2016.04.020. Immunity. 2016. PMID: 27192564 Free PMC article. Review.
Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.
Su Y, Chen D, Yuan D, Lausted C, Choi J, Dai CL, Voillet V, Duvvuri VR, Scherler K, Troisch P, Baloni P, Qin G, Smith B, Kornilov SA, Rostomily C, Xu A, Li J, Dong S, Rothchild A, Zhou J, Murray K, Edmark R, Hong S, Heath JE, Earls J, Zhang R, Xie J, Li S, Roper R, Jones L, Zhou Y, Rowen L, Liu R, Mackay S, O'Mahony DS, Dale CR, Wallick JA, Algren HA, Zager MA; ISB-Swedish COVID19 Biobanking Unit; Wei W, Price ND, Huang S, Subramanian N, Wang K, Magis AT, Hadlock JJ, Hood L, Aderem A, Bluestone JA, Lanier LL, Greenberg PD, Gottardo R, Davis MM, Goldman JD, Heath JR. Su Y, et al. Among authors: bluestone ja. Cell. 2020 Dec 10;183(6):1479-1495.e20. doi: 10.1016/j.cell.2020.10.037. Epub 2020 Oct 28. Cell. 2020. PMID: 33171100 Free PMC article. Clinical Trial.
537 results